The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 211
The Anthrax Vaccine: Is it Safe? Does it Work? Appendixes

OCR for page 211
The Anthrax Vaccine: Is it Safe? Does it Work? This page in the original is blank.

OCR for page 211
The Anthrax Vaccine: Is it Safe? Does it Work? Appendix A Statement of Task The committee will analyze available information, hold workshops, and make specific recommendations on technical aspects regarding the safety and efficacy of the licensed anthrax vaccine. The issues include the types and severity of adverse reactions, including gender (sex) differences; long-term health implications; inhalational efficacy of the vaccine against all known anthrax strains; correlation of animal models to safety and effectiveness in humans; validation of the manufacturing process focusing on, but not limited to, discrepancies identified by the Food and Drug Administration in February 1998; definition of vaccine components in terms of the protective antigen and other bacterial products and constituents; and identification of gaps in existing research.